Reply to Selcuk Guven, Selim Soyturk, and Thomas Herrmann’s Letter to the Editor re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111–15

From the first description of snare polypectomy of bladder tumour by Kitamura et al in 1980 [1] to the En Bloc Resection of Urothelium Carcinoma project published by Kramer and Herrmann et al. [2] in 2015, and the latest Global En Bloc Resection of Bladder Tumour (ERBT) Registry led by Teoh et al. [3,4], it has taken us 46 yr to reach a point where ERBT has gained sufficient critical mass and momentum, particularly in Asia and Europe [5]. There is also growing evidence that ERBT could enhance not only perioperative and pathological outcomes but also oncological results, especially when combined with intravesical Bacillus Calmette-Guerin therapy [6–8].